RELMADA THERAPEUTICS INC (RLMD:NASDAQ)
$6.55 0.18 (2.8257%)
Analysed RELMADA THERAPEUTICS INC (RLMD:NASDAQ) News Sources
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
02-04-2026
yahoo.com
Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics
06-04-2026
yahoo.com
Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?
13-04-2026
yahoo.com
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
05-05-2026
yahoo.com
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
06-05-2026
yahoo.com
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
Relmada Therapeutics Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
Relmada Therapeutics Inc (RLMD) Q1 2026 Earnings Call Highlights: Strong Financial Position and ...
13-05-2026
yahoo.com
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
11-06-2026
yahoo.com
What is the current price of RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The current price of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is $6.55.
RELMADA THERAPEUTICS INC (RLMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) since the previous trading day is $0.18.
RELMADA THERAPEUTICS INC (RLMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) since the previous trading day is 2.8257%.
What is the most recent average sentiment score for RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The most recent average sentiment score for RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The most recent sentiment for RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is .
SEC-8K** Filing Available For RELMADA THERAPEUTICS INC (RLMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.